XLO XILIO THERAPEUTICS INC Delisting Actions 8-K Filing 2024 - Nasdaq Notice Xilio Therapeutics received a notice from Nasdaq stating that its stock price has been below $1.00 for 30 consecutive days, and it has 180 days to regain compliance or face potential delisting.Get access to all SEC 8-K filings of the XILIO THERAPEUTICS INC